Non-leukemic granulocytic sarcoma presenting as multiple skin nodules: A rare case report

  • Pallavi Agrawal M.D., DNB, PDCC (Neuropathology) Department of Pathology, Postgraduate Institute of Medical Education & Research, Sector 12, Chandigarh 160012, India.
  • Narender Kumar Assistant Professor, Department of Haematology, Postgraduate Institute of Medical Education & Research, Sector 12, Chandigarh 160012, India
  • Deepak Bansal Additional Professor, Hematology-Oncology Division of Department of Pediatrics, Postgraduate Institute of Medical Education & Research, Sector 12, Chandigarh 160012, India.
  • Raje Nijhawan Professor in the Department of Cytology and Gynaecological Pathology, Postgraduate Institute of Medical Education & Research, Sector 12, Chandigarh 160012, India
Keywords: Bone marrow, fine needle aspiration cytology, flow-cytometry examination, non-leukemic granulocytic sarcoma

Abstract

Granulocytic sarcoma (GS) is a localized lesion comprising of immature granulocytes, monocytes, or both; involving extramedullary sites. GS with no evidence of leukemia (non-leukemic GS) is a very rare. Here we report a 10 year old male child who presented with facial and back swelling which was subsequently diagnosed as non-leukemic GS by flow-cytometry (FCM) examination on aspirated material.

References

1. Meis JM, Butler JJ, Osborne BM, Manning JT. Granulocytic sarcoma in nonleukemic patients. Cancer 1986; 58: 2697–709.

2. Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: Report of two cases and a review of 72 cases in the literature. Cancer 2002; 94:1739–46.

3. King A. A case of chloroma. Monthly J Med 1853; 17: 97.

4. Rodríguez Guerrero JM, Martín Hidalgo JR, Alonso Alejandro E, Pérez Ríos N, Roussel J, Rodríguez Pardo F et al. Granulocytic sarcoma (chloroma) of small bowel: an infrequent cause of intestinal obstruction. Gastroenterol Hepatol 2003; 26: 347–50.

5. Bénet C, Gomez A, Aguilar C, Delattre C, Vergier B, Beylot- Barry M, et al. Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases. Am J Clin Pathol 2011;135: 278–290.

6. Audouin J, Comperat E, Le Tourneau A, Camilleri-Broët S, Adida C, Molina T et al. Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis. Int J Surg Pathol. 2003; 11: 271-82.

7. Neiman RS, Barcos M, Berard C, Bonner H, Mann R, Rydell RE et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer 1981; 48: 1426-37.

8. Spahr J, Behm FG, Schneider V. Preleukemic granulocytic sarcoma of cervix and vagina: initial manifestation by cytology. Acta Cytol 1982; 26: 55-60.

9. Krause JR. Granulocytic sarcoma preceding acute leukemia: a report of six cases. Cancer 1979; 44: 1017-21.

10. Lan TY, Lin DT, Tien HF, Yang RS, Chen CY, Wu K. Prognostic factors of treatment outcomes in patients with granulocytic sarcoma. Acta Haematol. 2009; 122: 238-46.
Published
2016-02-25
Issue
Vol 3 No 1 (2016)
Section
Case Report

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).